Welcome to our dedicated page for Aptargroup news (Ticker: ATR), a resource for investors and traders seeking the latest updates and insights on Aptargroup stock.
AptarGroup, Inc. (NYSE: ATR) generates news across drug delivery, digital health and consumer dispensing technologies. As a global company serving pharmaceutical, beauty, food, beverage, personal care and home care markets, its announcements often highlight new delivery systems, clinical collaborations, acquisitions and financial updates that are relevant to investors and industry observers.
Recent news has featured Aptar Pharma’s nasal and ophthalmic platforms, such as LuerVax and Spray Divider being used in a Phase II clinical trial of an intranasal COVID-19 vaccine candidate, and Bidose liquid nasal spray systems delivering an FDA-approved treatment for paroxysmal supraventricular tachycardia. The company also reports on developments in eye care, including its Beat the Blink technology and preservative-free multidose dispensers, as well as broader portfolios of ophthalmic solutions.
Aptar’s Digital Health division appears frequently in updates related to connected health tools and data-driven care. Examples include the integration of the Migraine Buddy app with biometric data from wearable devices and FDA 510(k) clearance for HeroTracker Sense, a connected add-on for metered-dose inhalers within a respiratory disease management platform.
Investors following ATR news will also find earnings releases, segment performance commentary, conference participation announcements and information on capital markets activity, such as senior notes offerings. This news page brings together these items so readers can review Aptar’s latest product milestones, partnerships, digital health initiatives and financial communications in one place.
AptarGroup, Inc. (NYSE: ATR) has entered exclusive negotiations to potentially acquire all outstanding shares of Voluntis (ENXTPA: ALVTX) for €8.70 per share, valuing the company at approximately €78.8 million ($95.3 million). The acquisition aims to enhance Aptar's digital health portfolio by integrating Voluntis's digital therapeutic solutions, which support chronic disease management. This strategic move aligns with Aptar's focus on expanding digital capabilities and is expected to have a dilutive impact of $0.01 to $0.02 per share for FY 2022.
Summary not available.
AptarGroup, Inc. (NYSE:ATR) has unveiled its first fully recyclable mono-material pump named Future, aimed at the beauty and personal care markets. Made exclusively from polyethylene (PE), the pump is designed to enhance recycling processes and has received certifications from Cyclos-HTP and RecyClass. This innovation aligns with Aptar's commitment to sustainable practices and a circular economy. Future also features an advanced locking mechanism and is compliant with e-commerce standards. The launch will be showcased at the ChangeNow 2021 Global Summit on May 27.
AptarGroup (NYSE: ATR) has appointed Candace Matthews to its Board of Directors. With over 30 years of experience in healthcare, cosmetics, and consumer products, Matthews has previously held leadership roles at Amway and L’Oréal. Her expertise adds significant value to Aptar’s operations, aligning with the company's focus on innovation in drug delivery and consumer products. Currently, 45% of Aptar's Board is female, and all committees are chaired by women, highlighting the company's commitment to diversity.
AptarGroup, Inc. (NYSE: ATR) has been recognized in 3BL Media’s 100 Best Corporate Citizens ranking, highlighting its leadership and transparency in environmental, social, and governance (ESG) practices. The ranking evaluates major U.S. companies based on various ESG criteria. Aptar emphasizes its commitment to sustainability, aligning with United Nations Global Compact principles. President and CEO Stephan B. Tanda expressed pride in their corporate citizenship efforts, while Vice President Beth Holland noted ongoing commitments to stakeholder communication and global sustainability goals.
AptarGroup, Inc. (NYSE:ATR) announced a 5% price increase for its beauty, personal care, and home care products, effective June 1, 2021. This decision responds to sustained cost inflation on non-raw material inputs, including freight, energy, and labor. Marc Prieur, President of Aptar Beauty + Home, emphasized the necessity of these adjustments due to unprecedented cost increases and efforts to ensure safe production amid the COVID-19 pandemic. Sales representatives will provide customers with more details on the price changes.
AptarGroup, Inc. (NYSE:ATR) reported an 8% increase in first-quarter 2021 sales, totaling $777 million. Core sales rose 1%, driven by strong demand in the Food + Beverage segment. Reported earnings per share jumped 48% to $1.24, boosted by a non-cash gain of $0.19 per share from an equity investment. Adjusted earnings per share increased 10% to $1.09. The company expects second-quarter EPS guidance between $0.91 to $0.99, reflecting ongoing challenges in prescription drug markets but optimistic long-term growth potential. A quarterly dividend was increased by 6% to $0.38 per share.
AptarGroup, Inc. (NYSE: ATR) has declared a quarterly cash dividend of $0.38 per share, representing a 6% increase from the previous dividend. The payment date is May 19, 2021, for stockholders of record as of April 28, 2021. In 2020, Aptar returned $93 million to shareholders and is set for its 28th consecutive year of increased annual dividends. The company achieved a Total Shareholder Return of 102% over the past five years, outperforming its peer group and the S&P Midcap 400.
Summary not available.
AptarGroup, Inc. (NYSE:ATR) reported strong fourth quarter results with reported sales growing 12% to $749 million. Core sales increased 5%, driven by demand in Pharma and Food & Beverage segments. Earnings per share rose 8% to $0.79. For the year, reported sales grew 2% to $2.93 billion, but earnings per share fell 12% to $3.21 due to pandemic impacts. The company achieved record cash flow from operations of $570 million and declared a quarterly dividend of $0.36 per share, highlighting its commitment to shareholders.